Patents by Inventor Audrey PICARD

Audrey PICARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE AS ATR KINASE INHIBITORS
    Publication number: 20250179070
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.
    Type: Application
    Filed: February 12, 2025
    Publication date: June 5, 2025
    Inventors: Sheldon N. CRANE, Vouy Linh Truong, Abbas Abdoli, Jean-Francois Truchon, Cameron Black, Stéphanie Dorich, Lee Fader, Stéphanie Lanoix, Paul Jones, Miguel St-Onge, Audrey Picard, Cyrus M. Lacbay
  • Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as ATR kinase inhibitors
    Patent number: 12264155
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: April 1, 2025
    Assignee: Repare Therapeutics Inc.
    Inventors: Sheldon N. Crane, Vouy Linh Truong, Abbas Abdoli, Jean-François Truchon, Cameron Black, Stéphane Dorich, Lee Fader, Stéphanie Lanoix, Paul Jones, Miguel St-Onge, Audrey Picard, Cyrus M. Lacbay
  • SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS
    Publication number: 20220185809
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.
    Type: Application
    Filed: January 20, 2022
    Publication date: June 16, 2022
    Inventors: Sheldon N. Crane, Vouy-linh Truong, Abbas Abdoli, Jean-François Truchon, Cameron Black, Stéphane Dorich, Lee Fader, Stéphanie Lanoix, Paul Jones, Miguel St-Onge, Audrey Picard, Cyrus M. Lacbay
  • COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE AS ATR KINASE INHIBITORS
    Publication number: 20210277002
    Abstract: Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.
    Type: Application
    Filed: April 30, 2021
    Publication date: September 9, 2021
    Inventors: Sheldon N. CRANE, Vouy Linh TRUONG, Abbas ABDOLI, Jean-François TRUCHON, Cameron BLACK, Stéphane DORICH, Lee FADER, Stéphanie LANOIX, Paul JONES, Miguel ST-ONGE, Audrey PICARD, Cyrus M. LACBAY